Evidence map›Paper›PMID 31021732›Full record

ArticleRadiation research2019

Adrenergic Receptor Signaling Regulates the Response of Tumors to Ionizing Radiation.

Cameron R MacDonald, Mark J Bucsek, Guanxi Qiao, Minhui Chen, Lauren Evans, Daniel J Greenberg, Taylor P Uccello, Nicholas G Battaglia, Bonnie L Hylander, Anurag K Singh and 3 more

Open access · greenAbstract read
In one paragraph

Article in Radiation research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Pretreatment pain predicts perineural invasion in patients with head and neck squamous cell carcinoma.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Nerves in gastrointestinal cancer: from mechanism to modulations.Nature reviews. Gastroenterology & hepatology · 2022
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Cameron R MacDonaldDepartments of a Immunology.
Mark J BucsekDepartments of a Immunology.
Guanxi QiaoDepartments of a Immunology.
Minhui ChenDepartments of a Immunology.
Lauren EvansDepartments of a Immunology.
Daniel J GreenbergDepartments of a Immunology.
Taylor P Uccelloc Departments of Microbiology/Immunology.
Nicholas G Battagliac Departments of Microbiology/Immunology.
Bonnie L HylanderDepartments of a Immunology.
Anurag K Singhb Departments of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263.
Edith M Lordc Departments of Microbiology/Immunology.
Scott A Gerberc Departments of Microbiology/Immunology.
Elizabeth A RepaskyDepartments of a Immunology.
Institute of Immunology · HRCzech Academy of Sciences, Institute of Microbiology · CZRoswell Park Comprehensive Cancer Center · USUniversity of Rochester Medical Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
Washington University SPORE in Pancreatic CancerP50CA196510 · NCI · WASHINGTON UNIVERSITY · PI FIELDS, RYAN C · 2016 to 2020
$10.9M
The T32 Predoctoral Training Program in Immunology (PTPI)T32AI007285 · NIAID · UNIVERSITY OF ROCHESTER · PI Scott Andrew Gerber, JACQUES Robert · 1986 to 2026
$7.6M
Large heat shock proteins and their role in cancer therapyR01CA099326 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI REPASKY, ELIZABETH A, WANG, XIANG-YANG SHAWN · 2003 to 2020
$5.7M
IN SITU ANTITUMOR IMMUNITY AND EFFECTS OF RADIATIONR01CA028332 · NCI · UNIVERSITY OF ROCHESTER · PI LORD, EDITH M · 1985 to 2020
$5.0M
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitorsR01CA205246 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI REPASKY, ELIZABETH A · 2018 to 2022
$2.8M
Training the Next Generation of Physician ScientistsT35AI089693 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Mark Daniel Hicar · 2011 to 2026
$689k
NCI NIH HHS P30 CA016056NCI NIH HHS P50 CA196510NCI NIH HHS R01 CA028332NCI NIH HHS R01 CA099326NCI NIH HHS R01 CA205246NIAID NIH HHS T32 AI007285NIAID NIH HHS T35 AI089693
6 · The paper itself

Abstract

While ionizing radiation is a major form of cancer therapy, radioresistance remains a therapeutic obstacle. We have previously shown that the mandated housing temperature for laboratory mice (∼22°C) induces mild, but chronic, cold stress resulting in increased circulating norepinephrine, which binds to, and triggers activation of, beta-adrenergic receptors (β-AR) on tumor and immune cells. This adrenergic signaling increases tumor cell intrinsic resistance to chemotherapy and suppression of the anti-tumor immune response. These findings led us to hypothesize that adrenergic stress signaling increases radioresistance in tumor cells in addition to suppressing T-cell-mediated anti-tumor immunity, thus suppressing the overall sensitivity of tumors to radiation. We used three strategies to test the effect of adrenergic signaling on responsiveness to radiation. For one strategy, mice implanted with CT26 murine colon adenocarcinoma were housed at either 22°C or at thermoneutrality (30°C), which reduces physiological adrenergic stress. For a second strategy, we used a β-AR antagonist ("beta blocker") to block adrenergic signaling in mice housed at 22°C. In either case, tumors were then irradiated with a single 6 Gy dose and the response was compared to mice whose adrenergic stress signaling was not reduced. For the third strategy, we used an

Indexed as

AnimalsCell Line, TumorCell SurvivalCell Transformation, NeoplasticColonic NeoplasmsFemaleHumansMiceRadiation ToleranceReceptors, AdrenergicSignal TransductionTemperatureReceptors, Adrenergic

Identifiers

PMID31021732
PMCPMC6774253
OpenAlexW2941777080

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.